Leadership Overview
Tilray has 8 executives leading key functions including strategy, finance, operations, and regional management.
Driven by innovation, Tilray is dedicated to advancing the cannabis industry through rigorous research, cultivation, and distribution of high-quality medical cannabis and cannabinoids, impacting global health and wellness.
Driven by innovation, Tilray is dedicated to advancing the cannabis industry through rigorous research, cultivation, and distribution of high-quality medical cannabis and cannabinoids, impacting global health and wellness.
Leadership Roles at Tilray
Armando Fumanelli - Chief Executive Officer
Armando Fumanelli, the Chief Executive Officer at Tilray, directs the company's overarching strategic vision and operational execution. Fumanelli's leadership focuses on navigating the complex regulatory landscape of the cannabis industry, ensuring Tilray's continued growth and market expansion. This executive role involves driving innovation in product development and cultivation techniques, aligning all departments toward achieving key business objectives. By fostering a culture of excellence, Armando Fumanelli ensures Tilray maintains its position as a leader in medical cannabis research and distribution. The Chief Executive Officer's responsibilities extend to managing stakeholder relations and securing the company's long-term financial health and market competitiveness. Fumanelli's strategic oversight guarantees adherence to the highest standards of quality and compliance across all global operations.
Irwin Simon - Chairman & Chief Executive Officer
Irwin Simon, the Chairman & Chief Executive Officer at Tilray, guides the enterprise's strategic direction and corporate governance. Simon's extensive experience shapes Tilray's expansion into new markets and product categories, including the burgeoning cannabis beverage sector. This leadership position involves overseeing global operations, ensuring robust financial performance, and cultivating strategic partnerships that enhance market reach. By championing a forward-thinking approach, Irwin Simon drives Tilray's mission to lead the global cannabis market. The Chairman & Chief Executive Officer's role encompasses fostering innovation in cultivation and product development, maintaining rigorous quality control, and ensuring compliance with international regulations. Simon's vision propels Tilray's commitment to advancing cannabinoid science and delivering high-quality products worldwide.

Sebastien St-Louis - Founder, President & Chief Executive Officer
Sebastien St-Louis, the Founder, President & Chief Executive Officer at Tilray, established the company's foundational principles and continues to drive its innovative spirit. St-Louis's leadership focuses on pioneering advancements in medical cannabis research, cultivation, and distribution, ensuring Tilray remains at the forefront of the industry. This executive position involves setting the strategic agenda for product development and market penetration, particularly in the medical sector. By championing scientific rigor, Sebastien St-Louis ensures Tilray's commitment to quality and efficacy. The Founder, President & Chief Executive Officer's responsibilities include overseeing research initiatives, managing cultivation operations, and expanding the company's global footprint. St-Louis's dedication to cannabinoid science underpins Tilray's mission to improve patient outcomes through high-quality cannabis products.
Carl Merton - Chief Financial Officer
Carl Merton, the Chief Financial Officer at Tilray, directs the company's financial strategy, planning, and reporting. Merton's expertise is crucial in managing Tilray's fiscal operations, including budgeting, forecasting, and capital allocation across its diverse business units. This executive role involves ensuring financial compliance, optimizing profitability, and supporting strategic growth initiatives through sound financial management. By maintaining robust financial controls, Carl Merton safeguards Tilray's economic stability and investor confidence. The Chief Financial Officer's responsibilities extend to overseeing accounting, treasury, and investor relations, providing critical insights for executive decision-making. Merton's financial acumen is instrumental in navigating the complexities of the global cannabis market and driving sustainable revenue growth.
Thomas Adams - Interim Chief Financial Officer, Tilray Beer
Thomas Adams, the Interim Chief Financial Officer, Tilray Beer at Tilray, manages the financial operations specifically for the company's beverage division. Adams's role focuses on financial planning, analysis, and reporting to support the strategic growth and profitability of Tilray Beer. This executive position involves overseeing budgeting, cash flow management, and ensuring financial compliance within the beverage sector. By providing critical financial insights, Thomas Adams contributes to the successful market positioning and expansion of Tilray's beer brands. The Interim Chief Financial Officer, Tilray Beer's responsibilities include optimizing financial performance and supporting new product development initiatives. Adams's financial stewardship is key to the division's operational efficiency and market competitiveness.
Blair MacNeil - President, Canada
Blair MacNeil, the President, Canada at Tilray, leads the company's operations and strategic initiatives within the Canadian market. MacNeil's focus is on driving growth, expanding market share, and ensuring Tilray's leadership in the Canadian cannabis sector. This executive role involves overseeing cultivation, production, and distribution networks across Canada, aligning them with national regulatory requirements and market demands. By championing local market strategies, Blair MacNeil strengthens Tilray's presence and brand reputation in its home country. The President, Canada's responsibilities include managing regional teams, fostering key stakeholder relationships, and adapting global strategies to the specific nuances of the Canadian landscape. MacNeil's regional leadership is critical to Tilray's success in this key market.
Lloyd Brathwaite - Chief Information Officer
Lloyd Brathwaite, the Chief Information Officer at Tilray, oversees the company's technology infrastructure and digital transformation initiatives. Brathwaite's strategic leadership ensures that Tilray's IT systems support efficient operations, data security, and innovation across all departments. This executive role involves managing the development and implementation of technology solutions that enhance cultivation processes, distribution networks, and customer engagement. By leveraging cutting-edge technology, Lloyd Brathwaite drives operational excellence and competitive advantage for Tilray. The Chief Information Officer's responsibilities include cybersecurity, enterprise resource planning, and fostering a data-driven culture. Brathwaite's technological vision is essential for Tilray's continued expansion and its commitment to advancing cannabinoid science through robust information systems.
Roger Savell - Chief Administrative Officer
Roger Savell, the Chief Administrative Officer at Tilray, directs the company's administrative functions and operational support services. Savell's leadership ensures the smooth execution of daily business activities, including human resources, facilities management, and corporate governance support. This executive role involves optimizing internal processes to enhance efficiency and productivity across Tilray's global operations. By fostering a well-managed operational environment, Roger Savell supports the company's strategic objectives and employee well-being. The Chief Administrative Officer's responsibilities encompass developing and implementing administrative policies, managing vendor relationships, and ensuring compliance with workplace regulations. Savell's administrative oversight is vital for maintaining Tilray's operational integrity and supporting its mission.
Explore Leadership Teams in Manufacturing
Founded in 1891 and headquartered in Rahway, NJ, Merck & Co., Inc. is a global healthcare company delivering innovative solutions through prescription medicines, biologic therapies, vaccines, and animal health products.
Company Leadership
JY
RL
JH
Crinetics is a pharmaceutical company that develops much-needed therapies for people with endocrine diseases. Were here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. We partner with healthcare practitioners to ensure were solving real problems for them. And we build value in the company for investors by filling real market needs. Whatever brought you here, welcome.
Company Leadership
NL

Founded in 1969, Themis Medicar is a pharmaceutical company that specializes in manufacturing pharmaceuticals and medicinal chemicals for cardiology, pain management, anti-infectives, haematinics, and health and nutrition. Themis Medicare is located in India.
Company Leadership PN
TD
MS
HM
Revolution Medicines Inc is a pioneering biotechnology company committed to revolutionizing treatment for patients battling cancer. They are driven by a singular mission: the discovery, development, and delivery of innovative, targeted medicines, particularly focusing on what are known as RAS-addicted cancers, which represent a significant proportion of new human cancer diagnoses. The company has developed a groundbreaking tri-complex inhibitor platform to create a portfolio of RAS(ON) inhibitors, enabling a differentiated approach to target what was previously considered an undruggable molecular target in oncology. Through their tireless efforts and commitment to transformative science, they are building a deep pipeline of therapeutic candidates intended to change the standard of care for patients with these challenging diseases.
Company Leadership AS

SK